Trump Threatens Iran With 'Major Military Punishment' as Red Sea Attacks Push Oil Above $100 
Cathay Pacific Sees H1 Profit Surge on Strong Travel Demand 
Iran Rejects U.S.-Backed Ceasefire as Trump Escalates Military Threats, Oil Tops $100 
Wistron Opens $700M Texas AI Factory to Build Nvidia GB300 Superchips 
Gold Price Holds Above $4,130 as Fed Rate Outlook and Middle East Tensions Support Safe-Haven Demand 
OpenAI Australia Data Center Switches Cooling Strategy After Recycled Water Plan Fails 
Oil Prices Pull Back After Two-Week Rally as Middle East Supply Risks Persist 
Canada Opens Gordie Howe Bridge Without U.S. Officials as Trump Tariff Tensions Persist 
Wistron Opens $700M Texas AI Factory to Build Nvidia Superchips in U.S. 
Japan CPI Rises in June, but Core Inflation Stays Below BOJ’s 2% Target 
Australia ASIC Tightens Auditor Oversight After KPMG Leak Scandal 
Canada Vows Trade Fight as Trump Imposes 50% Tariffs 
South Korea Q2 GDP Beats Forecasts as AI Chip Exports Drive Growth 
SAP Beats Q2 Revenue Estimates as Cloud Backlog and Business AI Demand Drive Growth. 
Domino’s Weighs Appeal After Australian Court Rules Workers Were Misled on Pay 
BOJ Seen Holding Rates at 1% While Keeping Inflation Risk Warning 
A kind of paracetamol being marketed under the brand name Paraveganio is now available in Germany. What makes this medicine special is the fact that it is made with plant-based ingredients only, and it is the first of its kind in the world.
PlantBased News reported that the new medicinal drug is now vegan-certified and the world’s first to be registered with The Vegan Trademark, a trusted vegan labeling being managed by The Vegan Society, a recognized charity and the oldest vegan organization in the world.
Paraveganio was developed by a German pharma firm called Axunio. It was made using 100% plant-based ingredients, and it is now the first product to be certified as vegan by The Vegan Society. Paracetamol is used worldwide as a painkiller and can be purchased over-the-counter, but this medicine contains an animal-derived additive called the magnesium stearate.
Most pharma companies use this additive for lubricating properties in tablets and capsules. The stearic acid that it contains is an ingredient that is made with animal fats.
The plant-based Paraveganio paracetamol is free from magnesium stearate sourced from animals. Rather, this was taken from pure vegetable sources. Axunio guaranteed that its 500 mg. paracetamol tablets are 100% vegan drug that can be taken to relieve mild and moderate pain as well as reduce fever.
“We could not be prouder to be bringing the world’s first vegan-certified drug to the market. Of course, to have it certified by The Vegan Society’s Vegan Trademark – the gold standard in vegan labeling - makes it that much more special too,” Axunio’s product and business development manager, Julia von Horsten, said in a press release.
She added, “Many people are surprised to hear that the majority of medications, including over-the-counter products such as paracetamol, contain animal derivatives or have been tested on animals. We know there’s a gap in the market for vegan certified paracetamol and are so delighted to be able to offer our product to consumers.”
Meanwhile, this is a good innovation, but the Paraveganio tablets are only available in Germany at the moment. Then again, this may soon reach other countries as Axunio is planning to bring its vegan paracetamol to other markets too.
